https://www.worldpharmatoday.com/clinical-trails/eisai-and-purdue-pharma-announce-positive-topline-results-of-sunrise-2-the-second-phase-3-pivotal-study-of-lemborexant/ Magazine for the C-level Pharma Executives Thu, 18 Oct 2018 00:42:08 +0000 hourly 1 https://wordpress.org/?v=6.9.4